CYP2C19 and esophageal squamous cell carcinoma: The frequencies of the CYP2C19*2 GG, GA and AA genotypes in the ESCC patients differed significantly from those in the control group (χ2 = 43.56, P < 0.001, degrees of freedom = 2), with GA and AA being more frequent in patients than in controls.